Skip to main content
Caplight Logo









StimOxyGen

StimOxyGen

Private
ColeraineHealthcare & Life Scienceshttps://stimoxygen.com

Last Round

Seed

Mar 11, 2025

Total Funding Raised

$1.92M

Company Overview

StimOxyGen operates in Healthcare & Life Sciences and is based in Coleraine. Its latest recorded funding round was a Seed round in March 2025.

StimOxyGen is a biotechnology company developing oxygen-generating nanoparticles to treat hypoxic solid tumours and enhance the efficacy of radiotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

StimOxyGen Comparables

Compare StimOxyGen with similar companies based on industry and business-model similarity.

StimOxyGen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NuvOx Therapeutics
81%
Xerion Healthcare Limited
79%
KORTUC INC.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

StimOxyGen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 11, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sian Farrell

Chief Executive Officer, Co-Founder

Founding Team

For institutional investors. Book with your work email.

StimOxyGen Investors

Notable investors and investment history

StimOxyGen investors
InvestorRounds
Innovate UKSeed
QUBISSeed
Clarendon Fund ManagersSeed
DSW VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors grew 49% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

StimOxyGen Filings

Explore SEC and related filing metadata, where available.

StimOxyGen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about StimOxyGen's valuation, stock price, and market status.

Is StimOxyGen a public or private company?

StimOxyGen is a private company.

What is the current stock price of StimOxyGen?

StimOxyGen is a private company, so its shares have no public market price. Caplight tracks StimOxyGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is StimOxyGen worth (valuation)?

Valuation information for StimOxyGen is not publicly available.

Can I buy StimOxyGen stock?

StimOxyGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was StimOxyGen's last funding round?

StimOxyGen's most recent funding round was Seed on March 11, 2025.

Who are the main investors in StimOxyGen?

Key investors in StimOxyGen include DSW Ventures.

Will StimOxyGen IPO soon?

No public IPO plans have been announced for StimOxyGen.

How can I track StimOxyGen secondary market activity?

Caplight tracks bids, offers, and trades in StimOxyGen's shares on secondary markets.

Firmographic Details

HeadquartersColeraine
Employee Range5
Year Founded2021
Last FundingMar 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?